Загрузка...
Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: patient selection and perspectives
Heterozygous familial hypercholesterolemia (FH) is a genetic disorder characterized by high low-density lipoprotein cholesterol levels from birth, which exposes the arteries to high levels of atherogenic lipoproteins lifelong and results in a significantly increased risk of premature cardiovascular...
Сохранить в:
| Опубликовано в: : | Vasc Health Risk Manag |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5590683/ https://ncbi.nlm.nih.gov/pubmed/28919772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S130338 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|